Success Stories: A Postdoctoral Fellow from Vietnam Secures NIW Approval in the Field of Structural Biology, Despite an Interminable Waiting

Client’s Testimonial:

“Thank you for your message. I am so happy that my I-140 NIW was approved. I am very delighted and happy to work with you and I really appreciate it.”

On May 19^th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Structural Biology (Approval Notice).

General Field: Structural Biology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: Vietnam

State of Residence at the Time of Filing: Minnesota

Approval Notice Date: May 19^th, 2021

Processing Time: 19 months, 7 days

Case Summary:

A postdoctoral fellow with a Ph.D. in medicine engaged our services to help her file an NIW (National Interest Waiver) petition. As a part of our job, we evaluated her credentials to prove their veracity. Her intended research work on applying cryo-electron microscopy and crystallography to study proteins are of great importance in the United States because it improves our understanding of cancer, a disease that claims countless lives and imposes a substantial economic burden globally.

Thus, our team asked her to provide us with all the details of her academic and professional successes so that we could begin to prepare her NIW case and lead her to the NIW victory.

We observed that her research has been supported by funding grants from leading organizations, including the Carlsberg Foundation, Danish Cancer Society, Danish Council for Independent Research, Lundbeck Foundation, Novo Nordisk Foundation, National Research Foundation of Korea. The receipt of funding from these leading bodies indicates that her research has had a striking influence on the state of research in the field of structural biology.
In addition, we delved into her publications record, the 6 peer-reviewed journal articles (2 of them first-authored), published in some of the top-notch journals in her field, reflecting her peers’ recognition of the value of this research in the field, garnering the noble 72 citations. Also, many of her papers have in fact been among the most cited in the field.
It was noteworthy for us to add that her work benefits the United States by helping the nation combat the staggering healthcare costs associated with cancer. Her research provides physicians and researchers in the United States with the insights needed to better treat cancer, thus saving the people of the United States substantial sums. To support the aforementioned information, we added five recommendation letters, obtained by our client from other experts in the field, confirming that her work stands at the vanguard of new techniques to understand the ubiquity of cancer globally and treat it. One of them also stated:

“[Client’s] work contributes to the development of better cancer treatments, which is of great value to the United States. According to the National Institutes of Health’s National Cancer Institute, cancer has a pronounced impact on American society… Her next-generation work has already provided new knowledge about the cancers that threaten millions of lives in the United States. Her results to date provide sufficient justification for the nation to support her continued studies.”

We are happy that she achieved her NIW petition approval even after a long wait. USCIS spent a good amount of time adjudicating her case, however, our team’s efforts and her patience and cooperation paid off well. We truly thank her for trusting North America Immigration Law Group with her I-140 application, and we congratulate her on continuing to advance her chosen field.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.